Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-31

Clinical Trial Update: Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessing the combination of curcumin with FOLFOX chemotherapy in patients with inoperable colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • FOLFOX

Snippet

Sponsor: University of Leicester | Conditions: Colonic Cancer, Metastasis | Phase 1, Phase 2 | Status: COMPLETED